Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Search for other papers by Sylvain Roumeau in
Google Scholar
PubMed
Search for other papers by Joannice Thevenon in
Google Scholar
PubMed
CHU Clermont-Ferrand, Service de Biostatistiques, Clermont-Ferrand, France
Search for other papers by Lemlih Ouchchane in
Google Scholar
PubMed
CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Salwan Maqdasy in
Google Scholar
PubMed
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Marie Batisse-Lignier in
Google Scholar
PubMed
CHU Clermont-Ferrand, Inserm CIC 1405, Clermont-Ferrand, France
Search for other papers by Christian Duale in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service de chirurgie maxillo-faciale, Clermont-Ferrand, France
Search for other papers by Nathalie Pham Dang in
Google Scholar
PubMed
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Chirurgie Dentaire, Clermont-Ferrand, France
Search for other papers by Laurent Devoize in
Google Scholar
PubMed
acromegalic patient ( 12 , 13 ) but the link with the disease remains questionable. Most importantly, the dental state and the impact of oral manifestations on the patient’s quality of life are not reported at all in acromegaly. Therefore, we conducted a
Search for other papers by Ping Li in
Google Scholar
PubMed
Search for other papers by Fei Cheng in
Google Scholar
PubMed
Search for other papers by Lei Xiu in
Google Scholar
PubMed
discussion with a third reviewer (L X). Data were summarized statistically if they were available, sufficiently similar and of sufficient quality. All data should be expressed as means with standard deviations ( s.d. ). When information was reported for
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Anne Topping in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
-being and quality of life (QoL) ( 3 , 4 ). In adults, treatment with recombinant human growth hormone (GH) improves many of the clinical features associated with GHD ( 5 ). In young adults with severe GHD, GH treatment, following completion of linear
Search for other papers by Sondra O’Callaghan in
Google Scholar
PubMed
Search for other papers by Hanford Yau in
Google Scholar
PubMed
temporarily and often is refractory. Clinically, for the patient it negatively impacts quality of life, and patients can succumb to hypercalcemic crisis. Indeed, MAH not uncommonly, constitutes a metabolic oncologic emergency ( 1 , 2 ). Malignancy
Department of Ultrasound, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
Search for other papers by Yong Yu in
Google Scholar
PubMed
Search for other papers by Lin-Lin Shi in
Google Scholar
PubMed
Search for other papers by Hua-Wei Zhang in
Google Scholar
PubMed
Search for other papers by Qian Wang in
Google Scholar
PubMed
190 44.37 ± 13.88 iU22 Philip SonoVue Retrospective Surgical pathology Wei 2021 China English 48 39.9 ± 10.9 GE LOGIQ E9 Sonazoid Prospective Surgical pathology Quality assessment Two reviewers
Search for other papers by Anita Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Aart-Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Berthold Hauffa in
Google Scholar
PubMed
Search for other papers by Gabriele Häusler in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Mohamad Maghnie in
Google Scholar
PubMed
Search for other papers by Jesús Argente in
Google Scholar
PubMed
Search for other papers by Jean DeSchepper in
Google Scholar
PubMed
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by John W Gregory in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Fahrettin Keleştimur in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
Search for other papers by Sebastian Neggers in
Google Scholar
PubMed
Search for other papers by Vera Popovic-Brkic in
Google Scholar
PubMed
Search for other papers by Eleonora Porcu in
Google Scholar
PubMed
Search for other papers by Lars Sävendahl in
Google Scholar
PubMed
Search for other papers by Stephen Shalet in
Google Scholar
PubMed
Search for other papers by Bessie Spiliotis in
Google Scholar
PubMed
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
( 8 ) 6. Monitoring • Useful tools to monitor successful outcomes can include evaluation of specific disease markers (e.g., HbA1c), quality-of-life questionnaires, monitoring of attendance/adherence at clinic visits and reduced morbidity
Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Agnieszka Nomejko in
Google Scholar
PubMed
Search for other papers by Aleksandra Słowińska in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Katarzyna Pikosz in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
sexual dysfunction (FSD) ( 14 ). Stevanovic et al. also did not show differences in sexual function between Europid PCOS and healthy women in research on the QoL using the 50-item health-related quality of life questionnaire for polycystic ovary
Search for other papers by Molly L Tanenbaum in
Google Scholar
PubMed
Search for other papers by Persis V Commissariat in
Google Scholar
PubMed
events, fewer episodes of diabetic ketoacidosis (DKA), and better overall diabetes management (as assessed through HbA1c) ( 8 , 9 , 10 , 11 ). These advanced technologies have also shown benefits in improving diabetes distress and quality of life ( 12
Search for other papers by Natacha Driessens in
Google Scholar
PubMed
Search for other papers by Madhu Prasai in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Christophe De Block in
Google Scholar
PubMed
Search for other papers by Eva Van Caenegem in
Google Scholar
PubMed
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Search for other papers by Frank Nobels in
Google Scholar
PubMed
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Corinne Jonas in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
countries ( 1 ) and the lowest in Japan. Despite the advent of glucocorticoid replacement therapy in the early 1950s, life expectancy remains lower than in the general population ( 2 ), with increased morbidity and impaired quality of life ( 3 , 4
Department of Endocrinology and Diabetology, The Children’s Memorial Health Institute, Warsaw, Poland
Search for other papers by Agnieszka Bogusz in
Google Scholar
PubMed
Search for other papers by Svenja Boekhoff in
Google Scholar
PubMed
Search for other papers by Monika Warmuth-Metz in
Google Scholar
PubMed
Search for other papers by Gabriele Calaminus in
Google Scholar
PubMed
Search for other papers by Maria Eveslage in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
and the craniopharyngeal duct ( 1 , 2 , 3 , 4 , 5 , 6 ). Overall survival (OS) rates after CP are high (87–95% 20-year OS) ( 7 ). However, in long-term survivors, Quality of life (QoL) is frequently reduced due to morbidity caused by close